89bio, Inc. Net Change in Cash
89bio, Inc. reported Net Change in Cash of $3.02 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-08-08
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $189.34M.
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$98.59M, a 133.34% decline year-over-year.
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $295.68M, a 11933.98% increase year-over-year.
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $2.46M.
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$190.10M, a 172.86% decline from fiscal 2023.
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $260.91M, a 9224.73% increase from fiscal 2022.
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $2.80M.
- 89bio, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$45.75M, a 1043.71% decline from fiscal 2020.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|---|
| 2025-06-30 | $3.02M 10-Q · filed 2025-08-08 | |||||
| 2025-03-31 | $189.34M 10-Q · filed 2025-05-02 | |||||
| 2024-12-31 | -$190.10M 10-K · filed 2025-02-27 | |||||
| 2024-09-30 | -$224.75M 10-Q · filed 2024-11-07 | |||||
| 2024-06-30 | -$103.94M 10-Q · filed 2025-08-08 | |||||
| 2024-03-31 | -$98.59M 10-Q · filed 2025-05-02 | |||||
| 2023-12-31 | $260.91M 10-K · filed 2025-02-27 | |||||
| 2023-09-30 | $196.67M 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | $190.19M 10-Q · filed 2024-08-05 | |||||
| 2023-03-31 | $295.68M 10-Q · filed 2024-05-09 | |||||
| 2022-12-31 | $2.80M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $19.94M 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | $8.19M 10-Q · filed 2023-08-09 | |||||
| 2022-03-31 | $2.46M 10-Q · filed 2023-05-08 | |||||
| 2021-12-31 | -$45.75M 10-K · filed 2024-03-01 | |||||
| 2021-09-30 | -$58.49M 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | -$62.47M 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | -$30.18M 10-Q · filed 2022-05-12 | |||||
| 2020-12-31 | $4.85M 10-K · filed 2022-03-24 | |||||
| 2020-09-30 | $48.22M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$25.14M 10-Q · filed 2021-08-13 | |||||
| 2020-03-31 | -$7.80M 10-Q · filed 2021-05-14 | |||||
| 2019-12-31 | $82.10M 10-K · filed 2021-03-25 | |||||
| 2019-09-30 | $4.97M 10-Q · filed 2020-11-13 | |||||
| 2019-06-30 | $10.69M 10-Q · filed 2020-08-13 | |||||
| 2019-03-31 | -$4.17M 10-Q · filed 2020-05-13 | |||||
| 2018-12-31 | $11.26M 10-K · filed 2020-03-18 | |||||
| 2018-09-30 | $5.55M 10-Q · filed 2019-12-18 |